BIT 10.0% 2.7¢ biotron limited

The last 1/4ly did state “research and development expenditures...

  1. 997 Posts.
    lightbulb Created with Sketch. 320
    The last 1/4ly did state “research and development expenditures in the December quarter relate to three clinical trials which have completed expensive clinical stage. Hence, future expenditures will be lower.” We don’t know however the payment terms for CRO and what % was still to be completed end December. However R&D expense in December 1/4ly was historically very high.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
-0.003(10.0%)
Mkt cap ! $24.36M
Open High Low Value Volume
2.9¢ 2.9¢ 2.6¢ $49.52K 1.782M

Buyers (Bids)

No. Vol. Price($)
3 192359 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 27000 2
View Market Depth
Last trade - 16.10pm 12/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.